Access to Medicine Foundation

Breakthrough medicine only matters if it reaches the people who need it. Support the work that turns evidence into action – and action into impact. Invest in access now➡️accesstomedicinefoundation.org/donate #InvestinAccess #Access2Meds #HealthEquity #GlobalHealth @JayasreeKIyer

Meet our team at #WHA79 next week! @JayasreeKIyer, @claumartinezv, Margo Warren, Judith Sprunken, Tiphaine Aeby & Marcello Britto will join high-level meetings to discuss topics central to our work & share insights from our latest work. Learn more➡ accesstomedicinefoundation.org/event/the-acce… #WHA

Basic #healthcare services are still out of reach for half of the world’s population. We are committed to changing this. Help make global #HealthEquity a reality ➡️ accesstomedicinefoundation.org/donate #InvestinAccess #Access2Meds #GlobalHealth

Emerging markets are creating new opportunities for #pharma companies beyond high-income countries. Our latest trend analysis looks at product registration, supply & R&D activity across ten fast-growing markets. Read more ➡️ accesstomedicinefoundation.org/insights-resou… #Access2Meds #HealthEquity

@HelmsleyTrust, @FCDOGovUK, @MinBZ, @wellcometrust, @gatesfoundation

The Foundation is redefining the status quo in #GlobalHealth through our unique, multi-faceted model for change. Join us on the mission to make global health equity a reality➡️accesstomedicinefoundation.org/donate #InvestinAccess #Access2Meds #HealthEquity

In her latest op-ed for @pharmaboardroom, our CEO, @JayasreeKIyer, examines how geopolitical shifts are reshaping how medicines are developed, manufactured & delivered, & what this means for #GlobalHealth equity. Read more here➡️accesstomedicinefoundation.org/in-the-media/o… #Access2Meds #HealthEquity

For @devex, @_andrew_green asks: will #AntimicrobialResistance outpace research? The article examines #AMRB26 findings, revealing a shrinking pipeline, limited incentives for #innovation & ongoing barriers to access in #LMICs. Read more➡️accesstomedicinefoundation.org/in-the-media/w… #AMR #GlobalHealth

Ahead of #WorldMalariaDay, we spotlight our review outlining short- & long-term strategies for #pharma companies to safeguard current treatments & ensure next-generation antimalarials reach the people who need them most. Read more➡️accesstomedicinefoundation.org/insights-resou… #malaria #Access2Meds

We’re #hiring an Investor Engagement Officer in Amsterdam to help drive investor action on #Access2Meds. Work with institutional #investors, support collaboration & turn research into real-world impact. Learn more & apply➡️accesstomedicinefoundation.org/investor-engag… #vacancy #HiringAlert #NGOJobs

✍️ @GPeseckyt takes a closer look at #AMRB26 for @POLITICOEurope, highlighting a shrinking antimicrobial pipeline & fewer big #pharma players, as smaller biotechs face funding & scale challenges. Read more➡️accesstomedicinefoundation.org/in-the-media/n… #AMR #GlobalHealth #HealthEquity

Where is the fight against #AMR falling short? For @statnews, @edsilverman unpacks findings from #AMRB26, highlighting major gaps in paediatric R&D & lack of registered paediatric formulations in multiple countries in sub-Saharan Africa. Read more➡️accesstomedicinefoundation.org/in-the-media/l…

@AfricaCDC @AU_AMA_ @WHOAFRO @NEPAD_Agency @gatesfoundation @HelmsleyTrust @FCDOGovUK @DutchMFA @wellcometrust @UNITAID

We're pleased to announce a strategic partnership with @ECSA_HC, formalised through an MoU, to advance equitable #Access2Meds in sub-Saharan Africa. By combining regional leadership & global insight, we support more coordinated, system-level responses. 🔗accesstomedicinefoundation.org/who-we-are/how…

In March, we co-hosted the launch of #AMRB26 with @FlemingCentre, bringing together 100 leaders across sectors to discuss progress & next steps to tackle #AMR. Key insights are captured in a meeting report. Read it here➡️accesstomedicinefoundation.org/resource/turni… #GlobalHealth #HealthEquity

In the latest episode of The #HealthEquity podcast, our CEO, @JayasreeKIyer, speaks with James Reid, @HelmsleyTrust, about barriers to expanding access to #T1D care & how better alignment, integration & collaboration can help scale impact. Listen here➡️accesstomedicinefoundation.org/insights-resou…

✍️ For The @guardian, @JuliaKollewe reports on #AMRB26 findings, highlighting a 35% drop in antimicrobial R&D & uneven industry engagement. With #DrugResistance rising, can #innovation keep up? Read more➡️accesstomedicinefoundation.org/in-the-media/p… #AMR #pharma #HealthEquity #GlobalHealth

Are you a keen writer & editor who thrives on crafting crisp, clear prose? Join our team & work closely with our policy experts & researchers to help shape & structure findings & insights into digestible texts➡️accesstomedicinefoundation.org/writer-editor #hiring #HiringAlert #NGOJobs #AmsterdamJobs

The antimicrobial pipeline is shrinking. #AMRB26 finds a 35% decline in pipeline projects from large research-based companies since 2021, underscoring urgency of sustaining #innovation while ensuring new treatments reach patients most in need. Read more➡️accesstomedicinefoundation.org/news/tools-to-…

Access to anti-infectives depends on affordability & availability in practice, not supply alone. #AMRB26 shows access barriers are shaped by local contexts & require tailored strategies, yet only 44% of products are covered by such strategies. Read more➡️accesstomedicinefoundation.org/news/tools-to-…